176 filings
Page 6 of 9
6-K
b2cvt
14 Aug 12
Report of Foreign Issuer for the Period Ended June 30, 2012
12:00am
6-K
dm2g8 pwg96
15 May 12
Report of Foreign Issuer for the Period Ended March 31, 2012
12:00am
6-K
x49y1ndu yg3mhp
20 Apr 12
Notice of the Annual General Meeting of the Shareholders
12:00am
6-K
kdafxl4o 3lcl9
15 Mar 12
Report of Foreign Issuer for the Period Ended December 31, 2011
12:00am
6-K
qgtwu4
1 Mar 12
Nymox Announces U.S. Phase 2 Clinical Trial of NX-1207 for New Indication - Prostate Cancer
12:00am
6-K
g2nvu4
21 Feb 12
Recordati and Nymox Announce The Start of European Phase III Clinical Trial for NX-1207
12:00am
6-K
juwl0gyh
14 Nov 11
Report of Foreign Issuer for the Period Ended September 30, 2011
12:00am
6-K
owen3zc
12 Aug 11
Report of Foreign Issuer for the Period Ended June 30, 2011
12:00am
6-K
y6eby5 0i
13 May 11
Report of Foreign Issuer for the Period Ended March 31, 2011
12:00am
6-K
dnrxbvi
21 Apr 11
Notice of the Annual General Meeting of the Shareholders
12:00am
6-K
xsb0 e2oh
15 Mar 11
Report of Foreign Issuer for the Period Ended December 31, 2010
12:00am
6-K
5yuzr6s3n8zkg
17 Dec 10
Recordati and Nymox Pharmaceutical Corporation Announce European Licensing Agreement for NX-1207
12:00am
6-K
3qznp 8e9x5
12 Nov 10
Report of Foreign Issuer for the Period Ended September 30, 2010
12:00am
6-K
2khtwslhpkefz ytcbe
13 Aug 10
Report of Foreign Issuer for the Period Ended June 30, 2010
12:00am
6-K
sa0sm5v5yh wf3mem1u
14 May 10
Report of Foreign Issuer for the Period Ended March 31, 2010
12:00am
6-K
3lluua8
23 Apr 10
Notice of the Annual General Meeting of the Shareholders
12:00am
6-K
7w0t8col3vpc4
11 Mar 10
Report of Foreign Issuer for the Period Ended December 31, 2009
12:00am
6-K
1ld1v4
13 Nov 09
Report of Foreign Issuer
12:00am
6-K
38rx5gs32n
14 Aug 09
Report of Foreign Issuer
12:00am
6-K
v3k7 szfnyru4yah
3 Jun 09
Report of Foreign Issuer
12:00am